BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Fish and Richardson
Queensland Health
Federal Trade Commission
Novartis
AstraZeneca
US Department of Justice
Teva
McKinsey
Farmers Insurance

Generated: January 23, 2018

DrugPatentWatch Database Preview

Sincalide - Generic Drug Details

« Back to Dashboard

What are the generic sources for sincalide and what is the scope of sincalide freedom to operate?

Sincalide
is the generic ingredient in one branded drug marketed by Bracco and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Sincalide has ten patent family members in eight countries.

There are two drug master file entries for sincalide. One supplier is listed for this compound.
Summary for sincalide
International Patents:10
US Patents:1
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: 2
Suppliers / Packagers: 1
Bulk Api Vendors: 20
Clinical Trials: 3
Patent Applications: 458
Drug Prices:see low prices
DailyMed Link:sincalide at DailyMed
Pharmacology for sincalide
Ingredient-typeCholecystokinin
Drug ClassCholecystokinin Analog

US Patents and Regulatory Information for sincalide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bracco KINEVAC sincalide INJECTABLE;INJECTION 017697-001 Approved Prior to Jan 1, 1982 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for sincalide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bracco KINEVAC sincalide INJECTABLE;INJECTION 017697-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for sincalide

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fuji
Boehringer Ingelheim
Fish and Richardson
Colorcon
Harvard Business School
Federal Trade Commission
Queensland Health
Merck
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot